Aytu BioScience (AYTU) Misses Q2 EPS by 105c
Tweet
Share
E-mailGet Alerts AYTU Hot Sheet
Join SI Premium – FREE
Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($1.05), $1.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $15.2 million.
For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US's Greer Says Usmca Shifting To Rolling Talks, No Renewal - Bloomberg
- Crude Inventory Fell 3.8 Million Barrels Last Week, Says EIA
- ITG Opens At $18, IPO Priced At $16
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
